Hongtao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hongtao Xu has a total of 203 co-authors. Here are the top co-authors by number of shared publications:
- Wei Hou
Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, College of Pharmaceutical Science & Green Pharmaceutical Collaborative Innovation Center of Yangtze River Delta Region, Zhejiang University of Technology, Hangzhou 310014, China
35 shared publications - Peixiang Ma
Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China
28 shared publications Shuning Zhang
26 shared publicationsYuang Gu
Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University Shanghai 201210 China
22 shared publicationsJie Li
17 shared publicationsGuang Yang
Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology
15 shared publications
Latest Publications
- 17 June 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (26) , 8265-8270
A Multicomponent Chemistry for the Incorporation of N -Sulfonylguanidines into DNA-Encoded Libraries
To incorporate the N-sulfonylguanidine chemotype into DNA-encoded libraries (DELs), a cobalt-promoted, DNA-compatible N-sulfonylguanidine formation method has been developed. This method utilizes DNA-conjugated sulfonyl azides, isonitriles, and amines as readily accessible building blocks to enable modular, high-yielding synthesis of structurally diverse N-sulfonylguanidines, a privileged scaffold widely represented in biologically active small molecules.
- 17 June 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (26) , 8265-8270
A Multicomponent Chemistry for the Incorporation of N -Sulfonylguanidines into DNA-Encoded Libraries
To incorporate the N-sulfonylguanidine chemotype into DNA-encoded libraries (DELs), a cobalt-promoted, DNA-compatible N-sulfonylguanidine formation method has been developed. This method utilizes DNA-conjugated sulfonyl azides, isonitriles, and amines as readily accessible building blocks to enable modular, high-yielding synthesis of structurally diverse N-sulfonylguanidines, a privileged scaffold widely represented in biologically active small molecules.
- 25 March 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (13) , 4188-4194
Chemistry for the Incorporation of S -Aryl Dithiocarbamates into a DNA-Encoded Library
To enable the efficient incorporation of S-aryl dithiocarbamates into DNA-encoded libraries (DELs), we have developed a robust, sequential three-component copper-promoted C(sp2)-S coupling reaction. This protocol employs DNA-conjugated secondary amines, carbon disulfide (CS2), and commercially available aryl boronic acids as readily accessible substrates, affording structurally diverse DNA-conjugated S-aryl dithiocarbamates, motifs that constitute privileged scaffolds in medicinal chemistry and are recurrent in bioactive compounds.
- 25 March 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (13) , 4188-4194
Chemistry for the Incorporation of S -Aryl Dithiocarbamates into a DNA-Encoded Library
To enable the efficient incorporation of S-aryl dithiocarbamates into DNA-encoded libraries (DELs), we have developed a robust, sequential three-component copper-promoted C(sp2)-S coupling reaction. This protocol employs DNA-conjugated secondary amines, carbon disulfide (CS2), and commercially available aryl boronic acids as readily accessible substrates, affording structurally diverse DNA-conjugated S-aryl dithiocarbamates, motifs that constitute privileged scaffolds in medicinal chemistry and are recurrent in bioactive compounds.
- 26 February 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (10) , 3347-3353
Copper(II)-Catalyzed Radical-Type Selenium(II)–Nitrogen Exchange Chemistry between Benzoselenazolones and Hydrazines
The first radical-type selenium(II)-nitrogen exchange (SeNEx) chemistry was successfully developed, enabling rapid synthesis of diaryl selenides in moderate to excellent yields (46 examples, 21-89%). This chemistry brings arylhydrazines into the SeNEx platform and features mild and robust conditions, scalability, air and water tolerance, broad substrate scope, and good atomic economy, with N2 and H2O as the only waste. Furthermore, it tolerates a broad scope of transformable handles such as -OH, -NHBoc, nitro, phenol, ester, amide, sulfonamide, and N-unprotected heterocycles. The results of a mechanistic study support the radical pathway of this reaction. The utilization of this chemistry has been demonstrated by the further -OH- and -NHBoc-based elaboration, highlighting the great potential of this SeNEx chemistry in the synthesis of advanced selenide compounds with drug-like properties.
- 26 February 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (10) , 3347-3353
Copper(II)-Catalyzed Radical-Type Selenium(II)–Nitrogen Exchange Chemistry between Benzoselenazolones and Hydrazines
The first radical-type selenium(II)-nitrogen exchange (SeNEx) chemistry was successfully developed, enabling rapid synthesis of diaryl selenides in moderate to excellent yields (46 examples, 21-89%). This chemistry brings arylhydrazines into the SeNEx platform and features mild and robust conditions, scalability, air and water tolerance, broad substrate scope, and good atomic economy, with N2 and H2O as the only waste. Furthermore, it tolerates a broad scope of transformable handles such as -OH, -NHBoc, nitro, phenol, ester, amide, sulfonamide, and N-unprotected heterocycles. The results of a mechanistic study support the radical pathway of this reaction. The utilization of this chemistry has been demonstrated by the further -OH- and -NHBoc-based elaboration, highlighting the great potential of this SeNEx chemistry in the synthesis of advanced selenide compounds with drug-like properties.
- 14 November 2025
- Published by Elsevier in Drug Discovery Today
- Vol. 30 (12) , 104532
Combinatorial chemistry and click chemistry for the optimization of lipid nanoparticles to enhance RNA delivery
- 14 November 2025
- Published by Elsevier in Drug Discovery Today
- Vol. 30 (12) , 104532
Combinatorial chemistry and click chemistry for the optimization of lipid nanoparticles to enhance RNA delivery
- Open Access
- 3 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (1) , 225-239
Highly selective and AI-predictable Se–N exchange chemistry between benzoselenazolones and boronic acids for programmable, parallel, and DNA-encoded library synthesis
An unprecedented chemo-selective and multi-orthogonal SeNEx chemistry is reported as a powerful tool for programmable synthesis, on-plate nanomole-scale parallel synthesis and DNA-encoded library synthesis, thus accelerating functional discovery.
- 3 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (1) , 225-239
Open AccessHighly selective and AI-predictable Se–N exchange chemistry between benzoselenazolones and boronic acids for programmable, parallel, and DNA-encoded library synthesis
An unprecedented chemo-selective and multi-orthogonal SeNEx chemistry is reported as a powerful tool for programmable synthesis, on-plate nanomole-scale parallel synthesis and DNA-encoded library synthesis, thus accelerating functional discovery.
- 15 October 2025
- Published by Elsevier in Trends in Chemistry
- Vol. 7 (12) , 771-786
DNA-compatible chemistry for DNA-encoded libraries and beyond
- 15 October 2025
- Published by Elsevier in Trends in Chemistry
- Vol. 7 (12) , 771-786
DNA-compatible chemistry for DNA-encoded libraries and beyond
- 14 October 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (42) , 11859-11865
Tandem Nitro Reduction and Amide Condensation for the On-DNA Synthesis of Natural Product-Inspired Skeletons
To facilitate the efficient incorporation of natural product elements into DNA-encoded libraries, a robust, metal-free, DNA-compatible protocol for nitro reduction and in situ amide condensation has been developed. This methodology utilizes DNA-conjugated (hetero)aromatic nitro electrophiles and simple amino acids as starting materials, enabling the efficient synthesis of structurally diverse DNA-conjugated skeletons that represent core motifs commonly found in bioactive molecules or natural products.
- 14 October 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (42) , 11859-11865
Tandem Nitro Reduction and Amide Condensation for the On-DNA Synthesis of Natural Product-Inspired Skeletons
To facilitate the efficient incorporation of natural product elements into DNA-encoded libraries, a robust, metal-free, DNA-compatible protocol for nitro reduction and in situ amide condensation has been developed. This methodology utilizes DNA-conjugated (hetero)aromatic nitro electrophiles and simple amino acids as starting materials, enabling the efficient synthesis of structurally diverse DNA-conjugated skeletons that represent core motifs commonly found in bioactive molecules or natural products.
- Open Access
- 11 September 2025
- Published by Springer Nature in Research Square
Discovery of hALPL Agonists for Osteogenesis from A Selenium-containing DNA-encoded Natural Product Library
Tissue-nonspecific alkaline phosphatase (hALPL) deficiency or dysfunction is a key driver of bone developmental abnormalities. However, no small-molecule agonists are available for the therapeutic target hALPL—particularly its pathogenic mutants. We bridge this gap by developing an antibody maturation-inspired chemical maturation strategy that integrates DNA-encoded library (DEL) selection with parallel synthesis for rapid functional chemical discovery. Using a selenium-containing DNA-encoded natural product library (Se-nDEL), comprising 25900 selenium-containing derivatives and affinity-based selection, we identified hALPL-binding candidates. The candidates were further functionally matured via selenium-nitrogen exchange (SeNEx) chemistry-enabled in situ nanomole-scale parallel synthesis. These efforts culminated in the identification of E7, the first small-molecule hALPL agonist, which directly binds to and activates hALPL, thereby promoting osteogenesis both in vitro and in vivo. Notably, E7 demonstrated the ability to restore the enzymatic activities of seven pathogenic mutations, further highlighting its therapeutic potential. Our work establishes a scalable platform for agonist development, combining DEL-driven hit discovery with parallel synthesis for functional optimization, with broad applicability to challenging targets in bone biology and beyond.
- 11 September 2025
- Published by Springer Nature in Research Square
Open AccessDiscovery of hALPL Agonists for Osteogenesis from A Selenium-containing DNA-encoded Natural Product Library
Tissue-nonspecific alkaline phosphatase (hALPL) deficiency or dysfunction is a key driver of bone developmental abnormalities. However, no small-molecule agonists are available for the therapeutic target hALPL—particularly its pathogenic mutants. We bridge this gap by developing an antibody maturation-inspired chemical maturation strategy that integrates DNA-encoded library (DEL) selection with parallel synthesis for rapid functional chemical discovery. Using a selenium-containing DNA-encoded natural product library (Se-nDEL), comprising 25900 selenium-containing derivatives and affinity-based selection, we identified hALPL-binding candidates. The candidates were further functionally matured via selenium-nitrogen exchange (SeNEx) chemistry-enabled in situ nanomole-scale parallel synthesis. These efforts culminated in the identification of E7, the first small-molecule hALPL agonist, which directly binds to and activates hALPL, thereby promoting osteogenesis both in vitro and in vivo. Notably, E7 demonstrated the ability to restore the enzymatic activities of seven pathogenic mutations, further highlighting its therapeutic potential. Our work establishes a scalable platform for agonist development, combining DEL-driven hit discovery with parallel synthesis for functional optimization, with broad applicability to challenging targets in bone biology and beyond.
- 9 September 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (37) , 10582-10587
Integration of SuFEx and Sonogashira Cross-Coupling for the Synthesis of Structurally Diverse Aryl Acetylenes on DNA
To address the current limitations of DNA-compatible Sonogashira cross-coupling reactions capable of accommodating a broad range of commercially available phenolic building blocks (BBs), an in situ SuFEx-Sonogashira cross-coupling protocol has been developed. This protocol involves the conversion of readily accessible phenolic compounds into the corresponding aryl fluorosulfates within 96-well microplates via a highly efficient in situ liquid-phase SuFEx reaction, followed by Sonogashira cross-coupling with DNA-conjugated terminal alkynes.
- 9 September 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (37) , 10582-10587
Integration of SuFEx and Sonogashira Cross-Coupling for the Synthesis of Structurally Diverse Aryl Acetylenes on DNA
To address the current limitations of DNA-compatible Sonogashira cross-coupling reactions capable of accommodating a broad range of commercially available phenolic building blocks (BBs), an in situ SuFEx-Sonogashira cross-coupling protocol has been developed. This protocol involves the conversion of readily accessible phenolic compounds into the corresponding aryl fluorosulfates within 96-well microplates via a highly efficient in situ liquid-phase SuFEx reaction, followed by Sonogashira cross-coupling with DNA-conjugated terminal alkynes.